Your browser doesn't support javascript.
loading
PARP inhibition synergizes with CD47 blockade to promote phagocytosis by tumor-associated macrophages in homologous recombination-proficient tumors.
Liu, Yangyang; Xue, Rui; Duan, Xixi; Shang, Xiaoping; Wang, Ming; Wang, Fazhan; Zhu, Linyu; Zhang, Lijing; Ge, Xin; Zhao, Xianlan; Guo, Hongjun; Wang, Zhihong; Zhang, Lindong; Gao, Xiang; Shen, Airong; Sheng, Yuqiao; Qin, Zhihai.
Afiliación
  • Liu Y; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Xue R; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Duan X; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Shang X; Department of Medical Records, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Wang M; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Wang F; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhu L; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang L; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Ge X; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhao X; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Guo H; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Wang Z; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang L; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Gao X; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Shen A; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Sheng Y; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: fccshengyq@zzu.edu.cn.
  • Qin Z; Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Key Laboratory of Protein and Peptide Pharmaceuticals, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Univer
Life Sci ; 326: 121790, 2023 Aug 01.
Article en En | MEDLINE | ID: mdl-37211345
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article País de afiliación: China